GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
₹2,740.00
arrow_upward
+0.98%(+26.60) 1D
Nov 20, 3:30:03 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
₹2,701.00
High
₹2,748.00
Low
₹2,680.00
Mkt. cap
464.17B
Avg. vol.
94.32K
Volume
84.48K
Dividend
2.08%
Quarterly dividend
₹14.25
Ex-dividend date
May 29, 2026
P/E ratio
40.48
52-wk high
₹3,120.70
52-wk low
₹2,088.10
EPS
₹67.68
Shares outstanding
169.41M
No. of employees
3K
Open
₹2,701.00
High
₹2,748.00
Low
₹2,680.00
Mkt. cap
464.17B
Avg. vol.
94.32K
Volume
84.48K
Dividend
2.08%
Quarterly dividend
₹14.25
Ex-dividend date
May 29, 2026
P/E ratio
40.48
52-wk high
₹3,120.70
52-wk low
₹2,088.10
EPS
₹67.68
Shares outstanding
169.41M
No. of employees
3K
News stories
From web sources and news partners
Bloomberg.com
·
31 minutes ago
S&P 500 at 5,600? Crushing China’s AI Ambitions Has a Price
Traders Union
·
4 hours ago
Ryan Detrick: S&P 500 rose after seven-day losing streak in 16 out of 17 years since 1978
Crypto Briefing
·
2 hours ago
Nasdaq slides deeper as Nvidia rout drags S&P 500 and Dow into correction
TradingView
·
4 hours ago
Yardeni Trims S&P 500 Year-End Forecast Again, Says Bear Market Is Unlikely
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees3.1K
FoundedNov 13, 1924
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteindia-pharma.gsk.com